Detection test by immunoassay technique for shiga-like toxin (bacterial toxin)
A national market document for 87427, CY2024 — dated, cited, vintage-stamped, methods attached, forwardable. 12–18 pages; 6–9 figures, set by this market’s shape.
What the data shows
The Brief is a national document for 87427. Its findings page carries one finding per chapter, each opening the chapter that prints its figure and the table behind it — like these, from the United States, CY2024, the market on this page.
- 1Size and growth. The national market for 87427 ran ~178,815 all-Medicare services (estimated), 87,092 observed fee-for-service in CY2024. The market is up 3.3% year over year. 1 billing group bill it.
- 2Geography. NC, NJ, FL and AZ lead the state markets — together 46% of state-market volume.
What the Brief does not contain. Every table in the Brief is printed in it; nothing it rests on is held back. Figures cover Medicare fee-for-service claims; estimated all-Medicare figures are described in the methods.
This is a thin market on the record, so its Brief is a shorter document and says so. It carries the chapters the data supports — routed from this market's own record when the document is generated, never a fixed list. Every Brief also carries cover, findings, how-these-are-built, methods, appendix.
Two specimen briefs are free to read, whole, nothing removed: 99457 — remote monitoring → · 93000 — routine ECG →
← Back to the 87427 market on Nevvi — everything on that page stays free.